Share

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Prevention and Early Detection Resources:

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) appreciate the opportunity to comment on the USDA proposed rule to revise the child nutrition program requirements for meal patterns to be consistent with current nutrition science and federal dietary guidance.

Implementation of graphic warnings in the U.S. has been thwarted by tobacco industry legal challenges. The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN), along with our partners, have fought back in the judicial system, using litigation to both compel the U.S. Food and Drug Administration (FDA) to issue graphic warning regulations and help the U.S. Department of Justice (DOJ) defend the regulations finalized by FDA.

Tobacco use is one of the primary causes of cancer-related health disparities - disproportionately impacting people by race, ethnicity, sexual orientation, gender identity, disability status, mental health, income and education levels, and geographic location. Eliminating health disparities depends heavily on eliminating tobacco use. ACS CAN is pursuing evidence-based policies at the local, state, and federal levels that aim to reduce disparities and improve health outcomes for all individuals.

Significant tobacco tax increases are one of the most effective ways to prevent kids from starting to use tobacco and help adults quit. Substantial increases in cigarette tax rates also generate new revenue. In fact, every state that has significantly increased its cigarette tax has also boosted its state revenue - even after accounting for revenue loss due to beneficial declines in cigarette purchases resulting from the tax increase. 

For decades, tobacco companies have used flavors, in cigarettes, cigars, e-cigarettes, hookah, to lure and target youth and young people and expose them to a lifetime of nicotine addiction, disease, and premature death. Flavors, especially menthol, are known to improve the ease and use of a product by masking the tobacco’s harsh effects. ACS CAN urges lawmakers to protect public health, not Big Tobacco’s profits, by passing comprehensive tobacco control policies that apply to all tobacco products.

Many important public health policies are often developed and passed at the local level. Communities are also able to advance health equity when they can pass specific public health policies aimed at addressing local health disparities. But preemption—when a higher level of government revokes local authority—can restrict local policymakers’ ability to pass, implement, and enforce innovative and proactive public health policies. States should be able to set a minimum standard for public health protections, but they should not pre-empt local governments from going above and beyond that minimum standard.

Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.

The American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) appreciate the opportunity to comment on the proposed rule to update the definition for the implied nutrient content claim “healthy” to be consistent with current nutrition science and Federal dietary guidance.

Tobacco Control Resources:

Tobacco is still the number one cause of preventable death nationwide yet the current funding levels for tobacco control programs is not sufficient to prevent and address tobacco-related disparities. The U.S. Centers for Disease Control and Prevention (CDC) recommends that states annually spend 12% of funds from tobacco taxes and lawsuits on tobacco control programs.

The undersigned public health, medical and professional organizations write in strong support of your recent announcement that FDA will issue a proposed rule to reduce the nicotine level in cigarettes to non-addictive or minimally addictive levels. Such a standard would generate massive public health benefits, preventing millions of young people from smoking and dramatically reducing the number of people who die from tobacco-caused diseases. We urge you to move forward with this proposal as quickly as possible.

The undersigned public health and medical organizations write to express our deep
concern regarding the Food and Drug Administration’s (FDA) failure to take enforcement
actions against new tobacco products, including youth-appealing flavored e-cigarettes, that have
received marketing denial orders (MDOs) yet remain on the market illegally. FDA’s lack of
action against these products, which the agency claims are among its highest enforcement
priorities, imperils the health of our nation’s youth.

The undersigned organizations write to express our concern that FDA has yet to issue any decisions on applications for marketing orders for menthol-flavored e-cigarettes or e-liquid products. We believe granting any such orders would be inconsistent with the agency’s marketing denial orders for other non-tobacco flavored products and would be harmful to public health, particularly to the health of young people.

Screening Resources:

Early detection of breast and cervical cancer through screening can improve survival and reduce mortality by finding cancer at an early stage when treatment is more effective and less expensive. To save lives and reduce health care spending, the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is highly effective at detecting and treating breast and cervical cancer in people who may otherwise not be screened.

Early detection of cancer through screening can improve survival and reduce mortality by detecting cancer at an early stage when treatment is more effective. The most recent data show breast and lung cancer screening rates were lowest among American Indian and Alaska Native people compared to other race and ethnicities, and below all race and ethnicities combined for cervical, colorectal, and prostate cancer screening.

The Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is highly effective at detecting and treating breast and cervical cancer in low-income, uninsured, and underinsured women – who may otherwise not be screened. The American Cancer Society Cancer Action Network (ACS CAN) urges Congress to reauthorize this critical program by passing the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act.

For 30 years, the Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program has decreased disparities in breast and cervical cancer deaths.

In 2024, an estimated 13,820 people in the U.S. will be diagnosed with invasive cervical cancer, and 4,360 will die from the disease. Cervical cancer can affect any person with a cervix and most often is caused by certain types of human papillomavirus (HPV). Persistent HPV infection causes almost all cervical cancers but fortunately there is a safe and effective vaccine against HPV.

The PSA Screening for HIM Act  (H.R. 1826/S. 2821) would remove out-of-pocket costs for prostate cancer screening for those at highest risk for the disease. 

Approximately 1 in 8 women (13%) will be diagnosed with invasive breast cancer in her lifetime, and 1 in 39 women (3%) will die from breast cancer. In 2023, an estimated 297,790 women in the U.S. will be diagnosed with invasive breast cancer, and 43,170 will die from the disease. Despite the fact that U.S. breast cancer death rates have been declining for several decades, not all people have benefited equally from the advances in prevention, early detection, and treatments that have helped achieve these lower rates.

Critical steps are needed to increase lung cancer screening rates across the country and also increasing to access comprehensive cessation benefits, especially among individuals with limited incomes that are disproportionately burdened by lung cancer.

ACS CAN supports H.R. 4286 to eliminate barriers and increase access to lung cancer screening and expand coverage for tobacco cessation.

Breast cancer is the second most diagnosed cancer among women in the U.S. and the second leading cause of cancer death among women after lung cancer. Ensuring breast cancer screening services ― including diagnostic and follow-up testing ― are covered without no cost-sharing is essential to increasing access and expanding coverage of breast cancer screening.

ACS CAN supports H.R. 3086 to increase access to no cost breast cancer screening, diagnostic and follow-up testing.

Healthy Eating and Active Living Resources:

ACS and ACS CAN submitted comments and recommendations regarding the White House Conference on Hunger, Nutrition, and Health, planned to be held in September 2022. 

ACS and ACS CAN submitted comments on Topics and Scientific Questions for the 2025-2030 Dietary Guidelines for Americans. 

  •